Some Counterclaims Dropped From Coreg Patent Suit
Teva Pharmaceutical Industries Ltd. scored a win Thursday when a judge dropped a handful of counterclaims, including one alleging antitrust violations, from its patent infringement suit against Canadian generics maker Apotex...To view the full article, register now.
Already a subscriber? Click here to view full article